(Q42167764)

17 October 2017

title

An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder (English)

1 reference

attention deficit hyperactivity disorder

17 October 2017

1 reference

1 reference

1 reference

10

Joseph Biederman

1 reference

17 October 2017

2

Jefferson B Prince

1 reference

17 October 2017

Stephanie L Van Patten

4

object named as

Stephanie L Van Patten

1 reference

17 October 2017

1

Timothy E Wilens

1 reference

17 October 2017

Thomas Spencer

3

1 reference

17 October 2017

Robert Doyle

5

1 reference

17 October 2017

Kristine Girard

6

1 reference

17 October 2017

Paul Hammerness

7

1 reference

17 October 2017

Sarah Goldman

8

1 reference

17 October 2017

Sarah Brown

9

1 reference

17 October 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

17 October 2017

published in

Biological Psychiatry

1 reference

17 October 2017

volume

54

1 reference

17 October 2017

issue

1

1 reference

17 October 2017

page(s)

9-16

1 reference

Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS).

17 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Gender and comorbid psychopathology in adolescents with alcohol dependence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

An Inventory for Measuring Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Sensitivity and specificity of clinical markers for the diagnosis of bipolar II disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Resolved: mania is mistaken for ADHD in prepubertal children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Systematic chart review of the pharmacologic treatment of comorbid attention deficit hyperactivity disorder in youth with bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Male testosterone linked to high social dominance but low physical aggression in early adolescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Prior stimulant treatment in adolescents with bipolar disorder: association with age at onset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Diagnostic reliability of the history of hypomania in bipolar II patients and patients with major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

How reliable are maternal reports of their children's psychopathology? One-year recall of psychiatric diagnoses of ADHD children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Bipolar and antisocial disorders among relatives of ADHD children: parsing familial subtypes of illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

A double-blind study comparing idazoxan and bupropion in bipolar depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

The assessment of anxiety states by rating

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

A rating scale for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

The Measurement of Observer Agreement for Categorical Data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Nicotinic systems and cognitive function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Comorbidity of attention deficit hyperactivity disorder with early- and late-onset bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Cholinergic mediation of the inhibitory effect of methylphenidate on neuronal activity in the reticular formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Attention-deficit/hyperactivity disorder and comorbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Bipolar depression: pharmacotherapy and related therapeutic strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Bupropion treatment of attention-deficit hyperactivity disorder in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

A family study of manic-depressive (bipolar I) disease. Is it a distinct illness separable from primary unipolar depression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

A rating scale for mania: reliability, validity and sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901664-5

10.1016/S0006-3223(02)01664-5

7 January 2021

Identifiers

DOI

1 reference

17 October 2017

1 reference